GlassScriptPhysician profile
Bradley L Boyd
NPI 1134384720
$540,144.65
in general payments reported to CMS, 2019-2025
22 companies · $94K in 2025
The $94K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73K · 2020: $69K · 2021: $95K · 2022: $67K · 2023: $66K · 2024: $76K · 2025: $94K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $193K · Travel and Lodging: $37K · Food and Beverage: $5,845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $193,175.00 |
| Travel and Lodging | $36,865.97 |
| Food and Beverage | $5,845.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $515,769.02 | 2019-2025 | Mako, Insignia, Aequalis |
| Pacira Therapeutics, INC. | $23,414.51 | 2019-2021 | |
| Amgen INC. | $147.28 | 2024-2025 | Krystexxa |
| Avanos Medical | $140.29 | 2021 | |
| Depuy Synthes Sales INC. | $121.08 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $68.72 | 2021-2023 | Zilretta, Iovera |
| Ethicon US, LLC | $63.46 | 2019-2025 | Vistaseal |
| Horizon Therapeutics Plc | $58.13 | 2019-2020 | |
| Davol INC. | $53.89 | 2025 | Arista |
| Fidia Pharma USA INC. | $44.50 | 2019-2020 | |
| Smith+Nephew, INC. | $43.10 | 2019 | |
| Bioventus LLC | $41.98 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $38.97 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $19.65 | 2022 | |
| Dynasplint Systems INC. | $19.52 | 2025 | Dynasplint |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $17.55 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $16.88 | 2025 | |
| Wright Medical Technology, INC. | $14.78 | 2019 | |
| Osiris Therapeutics INC. | $14.76 | 2019 | |
| Integra Lifesciences Corporation | $13.44 | 2020 | |
| Orthofix Medical, INC. | $11.91 | 2021 | |
| Abbott Laboratories | $11.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.